BUY Raghav Productivity Enhancers Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))10 Sept 2026via NDTV Profit
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Raghav Productivity Enhancers Ltd has been assigned a credit rating of Crisil A/Stable for its long-term bank facilities amounting to Rs. 15.00 crore. This rating is an upgrade from its previous ratin
BSE · Company Update·9 Sept · yesterday
Raghav Productivity Enhancers Ltd. (RPEL) and TRL Krosaki Refractories Ltd. are forming a joint venture to establish a 350,000 MTPA silica ramming mass manufacturing facility in Odisha with an initial
BSE · Company Update·7 Sept · 4d ago
Raghav Productivity Enhancers Ltd. will enter into a Joint Venture Agreement with TRL Krosaki Refractories Limited to establish a silica ramming mass manufacturing unit in Odisha. Raghav will hold 80%
BSE · Company Update·4 Sept · 1w ago
Raghav Productivity Enhancers Ltd will enter a Joint Venture with TRL Krosaki Refractories Ltd to set up a silica ramming mass manufacturing unit in Odisha. Raghav will hold 80% of the JV.
BSE · Others·4 Sept · 1w ago
Raghav Productivity Enhancers Limited will form a Joint Venture with TRL Krosaki Refractories Limited to set up a silica ramming mass manufacturing unit in Odisha. Raghav will hold 80% and TRLK 20% of
NSE · Outcome of Board Meeting·4 Sept · 1w ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

